Re: Furutani T, Takeyama K-i., Tanabe M, Koutoku H, Ito S, Taniguchi N, Suzuki E, Kudoh M, Shibasaki M, Shikama H, and Kato S (2005) Human expanded polyglutamine androgen receptor mutants in neurodegeneration as a novel ligand target. J Pharmacol Exp Ther 315:545–552; doi:10.1124/jpet.105.087643

doi:10.1124/jpet.114.03er14b

RetractionNotice of Retraction

Re: Furutani T, Takeyama K-i., Tanabe M, Koutoku H, Ito S, Taniguchi N, Suzuki E, Kudoh M, Shibasaki M, Shikama H, and Kato S (2005) Human expanded polyglutamine androgen receptor mutants in neurodegeneration as a novel ligand target. J Pharmacol Exp Ther 315:545–552; doi:10.1124/jpet.105.087643

Journal of Pharmacology and Experimental Therapeutics March 2014, 348 (3) 493; DOI: https://doi.org/10.1124/jpet.114.03er14b

Article
Info & Metrics
eLetters
PDF

See original article:

RETRACTION: Human Expanded Polyglutamine Androgen Receptor Mutants in Neurodegeneration as a Novel Ligand Target - November 01, 2005

Following an institutional investigation, the article referenced above has been found to contain an over-manipulation of the data shown in Fig. 2D.

Because the authors are unable to provide the raw sets for the data, the corresponding author, Dr. Shigeaki Kato, has requested that this article be retracted.

PreviousNext

In this issue

Journal of Pharmacology and Experimental Therapeutics

Vol. 348, Issue 3

1 Mar 2014

Table of Contents
Table of Contents (PDF)
About the Cover
Index by author
Editorial Board (PDF)
Front Matter (PDF)

Download PDF

Article Alerts

User Name *

Password *

Email *

Email Article

Thank you for sharing this Journal of Pharmacology and Experimental Therapeutics article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following Re: Furutani T, Takeyama K-i., Tanabe M, Koutoku H, Ito S, Taniguchi N, Suzuki E, Kudoh M, Shibasaki M, Shikama H, and Kato S (2005) Human expanded polyglutamine androgen receptor mutants in neurodegeneration as a novel ligand target. J Pharmacol Exp The…

Message Subject (Your Name) has forwarded a page to you from Journal of Pharmacology and Experimental Therapeutics

Message Body (Your Name) thought you would be interested in this article in Journal of Pharmacology and Experimental Therapeutics.

Your Personal Message

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Citation Tools

RetractionNotice of Retraction

Re: Furutani T, Takeyama K-i., Tanabe M, Koutoku H, Ito S, Taniguchi N, Suzuki E, Kudoh M, Shibasaki M, Shikama H, and Kato S (2005) Human expanded polyglutamine androgen receptor mutants in neurodegeneration as a novel ligand target. J Pharmacol Exp Ther 315:545–552; doi:10.1124/jpet.105.087643

Journal of Pharmacology and Experimental Therapeutics March 1, 2014, 348 (3) 493; DOI: https://doi.org/10.1124/jpet.114.03er14b

Citation Manager Formats

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

RetractionNotice of Retraction

Re: Furutani T, Takeyama K-i., Tanabe M, Koutoku H, Ito S, Taniguchi N, Suzuki E, Kudoh M, Shibasaki M, Shikama H, and Kato S (2005) Human expanded polyglutamine androgen receptor mutants in neurodegeneration as a novel ligand target. J Pharmacol Exp Ther 315:545–552; doi:10.1124/jpet.105.087643

Journal of Pharmacology and Experimental Therapeutics March 1, 2014, 348 (3) 493; DOI: https://doi.org/10.1124/jpet.114.03er14b

Share This Article:

Tweet Widget
Facebook Like
Google Plus One

Jump to section

Article
Info & Metrics
eLetters
PDF

Cited By...

More in this TOC Section

Notice of Retraction: Harada S, Yamazaki Y, and Tokuyama S (2013) Orexin-A Suppresses Postischemic Glucose Intolerance and Neuronal Damage through Hypothalamic Brain-Derived Neurotrophic Factor, J Pharmacol Exp Ther, 344: 276-285; DOI: https://doi.org/10.1124/jpet.112.199604
Re: Schneider-Stock R, Diab-Assef M, Rohrbeck A, Foltzer-Jourdainne C, Boltze C, Hartig R, Schönfeld P, Roessner A, and Gali-Muhtasib H (2005) 5-aza-Cytidine Is a Potent Inhibitor of DNA Methyltransferase 3a and Induces Apoptosis in HCT-116 Colon Cancer Cells via Gadd45- and p53-Dependent Mechanisms. J Pharmacol Exp Ther February 2005 312:525–536; doi:10.1124/jpet.104.074195
Re: Norman AB, Tabet MR, Norman MK, and Tsibulsky VL (2014) Maintained Cocaine Self-Administration Is Determined by Quantal Responses: Implications for the Measurement of Antagonist Potency. J Pharmacol Exp Ther 348:311–315; doi:10.1124/jpet.113.210690

Show more Notice of Retraction

Main menu

User menu

Search

Re: Furutani T, Takeyama K-i., Tanabe M, Koutoku H, Ito S, Taniguchi N, Suzuki E, Kudoh M, Shibasaki M, Shikama H, and Kato S (2005) Human expanded polyglutamine androgen receptor mutants in neurodegeneration as a novel ligand target. J Pharmacol Exp Ther 315:545–552; doi:10.1124/jpet.105.087643

See original article:

In this issue

Re: Furutani T, Takeyama K-i., Tanabe M, Koutoku H, Ito S, Taniguchi N, Suzuki E, Kudoh M, Shibasaki M, Shikama H, and Kato S (2005) Human expanded polyglutamine androgen receptor mutants in neurodegeneration as a novel ligand target. J Pharmacol Exp Ther 315:545–552; doi:10.1124/jpet.105.087643

Citation Manager Formats

Related Articles

Cited By...

More in this TOC Section

Similar Articles

Navigate

More Information

ASPET's Other Journals